Citations

Mayo Clinic

Showing 10 of 108602 citations.

International survey of knowledge, attitudes, and practices of cardiologists regarding prevention and management of cardiac implantable electronic device infections
DeSimone, Daniel C. , Chahal, C. Anwar A. , Asirvatham, Samuel J. , Friedman, Paul A. , Sohail, M. Rizwan , Chahal, Anwar A, Friedman, Paul A , Asirvatham, Samuel J , Sohail, M Rizwan , Chahal, Choudhary Anwar A , DeSimone, Daniel C , DeSimone, Christopher V. , Baddour, Larry M.

Pacing and Clinical Electrophysiology | August 28, 2017 | Volume: 40 | Issue: 11 | Pages: 1260-1268

10.1111/pace.13183 | PMID 28846153 Get It

AbstractBackgroundCardiovascular implantable electronic devices (CIEDs) can be life‐saving. However, complications from CIED infection can be life‐threatening, often requiring device removal. Despite publication of CIED infection management guidelines, there remains marked variation in clinical practice.ObjectiveTo better understand and quantify these differences, we conducted a multinational survey of practitioners of CIED management.MethodsAn electronic survey was sent to Heart Rhythm Society members, spanning 70 countries across six continents. All responses were collected anonymously.Results227 out of 3,600 (6.3%) responded to the survey. The majority of surveys were completed by practitioners from the United States (168; 68.3%) and 53.8% of these practiced in academic medical centers. The large majority (92.7%) of sites had protocols to ensure appropriate timing of prophylactic antibiotics. Superficial (incisional) site infections were treated with antibiotics alone 52.5% of the time (consistent with guidelines); in contrast, deep pocket infections were treated with antibiotics (with device removal) in accordance to guidelines only 37.4% of the time. Almost all providers (98.7%) were inclined to perform complete hardware removal in cases of CIED‐related endocarditis. In contrast, 82.2% of survey participants suggested complete CIED system removal in patients with an occult Gram‐positive bacteremia, 65.5% with occult Gram‐negative bacteremia, and 59.3% with prolonged bacteremia due to a source other than CIED.ConclusionsThese data suggest wide variability in clinical practice in managing CIED infection with significant deviations from published guidelines. There is critical need to increase awareness and develop institutional protocols to ensure adherence with evidence‐based guidelines to optimize outcomes.
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity
Iqbal, Anoop , Dahl, Amanda , Lteif, Aida, Kumar, Seema , Iqbal, Anoop Mohamed, Dahl, Amanda R, Kumar, Seema

Children | August 28, 2017 | Volume: 4 | Issue: 9 | Pages: 80

10.3390/children4090080 | PMID 28846662 Get It

Severe obesity is associated with abnormal lipids and increased risk for cardiovascular disease. Obesity is a risk factor for vitamin D deficiency. We examined relationship between 25-hydroxy vitamin D (25(OH)D) concentrations and lipids in children with severe obesity. Medical records of 376 children were reviewed. Linear regression models and logistic regression were used to examine the relationship between 25(OH)D and lipids after adjustment for age, gender, season of blood draw, body mass index (BMI) z-score, and BMI % of 95th percentile. Two-hundred sixty-three out of 376 children (70%) had 25(OH)D concentrations < 30 ng/mL. Concentrations of 25(OH)D were positively correlated with those of high-density lipoprotein cholesterol (HDL-C) (r2 = 0.08, r = 0.22, β = 0.16, 95% CI = 0.05–0.27, p = 0.004). HDL-C was lower in children with 25(OH)D < 30 ng/mL (n = 263) compared to those with 25(OH)D ≥ 30 ng/mL (n = 113) (41.3 ± 10.2 vs. 46.4 ± 12 mg/dL, p < 0.0001). Children with 25(OH)D concentrations < 30 ng/mL had greater adjusted odds of low HDL-C (<40 mg/dL) compared with those with 25(OH)D ≥ 30 ng/mL (47.9% vs. 29.2%, OR 2.15 (1.33–3.51), p = 0.0019). Total cholesterol and non-HDL-C were not correlated with 25(OH)D concentrations. Vitamin D deficiency is highly prevalent in children with severe obesity. Prospective clinical trials are warranted to determine if vitamin D supplementation can improve HDL-C and potentially decrease risk for cardiovascular disease in children with obesity.
Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials
Strawn, Jeffrey R. , Mills, Jeffrey A. , Cornwall, Gary J. , Mossman, Sarah A. , Varney, Sara T., Keeshin, Brooks , Croarkin, Paul E. , Croarkin, Paul E , Strawn, Jeffrey R

Journal of Child and Adolescent Psychopharmacology | August 28, 2017 | Volume: 28 | Issue: 1 | Pages: 2-9

10.1089/cap.2017.0060 | PMID 28846022 Get It

A Case-Controlled Investigation of Tactile Reactivity in Young Children With and Without Global Developmental Delay
Barney, Chantel C., Tervo, Raymond C., Wilcox, George L. , Symons, Frank J. , Burkitt, Chantel C. , Tervo, Raymond

American Journal on Intellectual and Developmental Disabilities | August 28, 2017 | Volume: 122 | Issue: 5 | Pages: 409-421

10.1352/1944-7558-122.5.409 | PMID 28846038 Get It

Abstract Assessing tactile function among children with intellectual, motor, and communication impairments remains a clinical challenge. A case control design was used to test whether children with global developmental delays (GDD; n = 20) would be more/less reactive to a modified quantitative sensory test (mQST) compared to controls (n = 20). Reactivity was indexed by blinded behavioral coding across vocal, facial, and gross motor responses during the mQST. On average the children with GDD were significantly more reactive than controls to most tactile sensory modalities including light touch (p = .034), pin prick (p = .008), cool (p = .039), pressure (p = .037), and repeated von Frey (p = .003). The results suggest the mQST approach was feasible and highlights the GDD sample was more reactive than controls to a range of stimuli.
Femoral Derotation Osteotomy Technique for Excessive Femoral Anteversion
Hartigan, David E. , Perets, Itay , Walsh, John P. , Domb, Benjamin G.

Arthroscopy Techniques | August 28, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.05.027 | PMID 29354448 Get It

Abstract Excessive femoral anteversion may lead to increasing stress placed on the anterior acetabulum and soft tissues, which can predispose to intra‐articular hip pathology. By addressing the excessive femoral anteversion in combination with intra‐articular hip pathology, the results will be durable over time. This technique details how to perform a femoral derotation osteotomy for excessive femoral anteversion after addressing intra‐articular pathology with hip arthroscopy in one surgical intervention. This allows the surgeon to address both the underlying pathoanatomy and the resultant intra‐articular sequelae. Technique Video video See video under supplementary data.
Arthroscopic Iliopsoas Release at the Level of the Lesser Trochanter Following Total Hip Arthroplasty
Patel, Karan A. , Goodwin, Jill A., Brown, Jaycen C., Hartigan, David E. , Patel, Karan , Chhabra, Anikar

Arthroscopy Techniques | August 28, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.05.023 | PMID 29354451 Get It

Abstract Iliopsoas impingement is an uncommon cause of pain after total hip arthroplasty. If pain persists after a trial of conservative treatment, surgical intervention can alleviate the patient's symptoms. Multiple advantages exist to release the iliopsoas tendon at the level of the lesser trochanter. The purpose of this Technical Note is to demonstrate a technique for arthroscopic release of the iliopsoas tendon at the lesser trochanter after total hip arthroplasty. Technique Video video See video under supplementary data.
Advancing Guideline Development in the United States: A Call to Action by the US GRADE Network
Morgan, Rebecca L. , Sultan, Shahnaz , Murad, M. Hassan , Helfand, Mark , Falck–Ytter, Yngve , Murad, M Hassan , Mustafa, Reem A , Dahm, Philipp , Qaseem, Amir , Morgan, Rebecca L

American Journal of Medical Quality | August 28, 2017 | Volume: 33 | Issue: 2 | Pages: 117-118

10.1177/1062860617726855 | PMID 28845692 Get It

Comparison of Bioavailability of Single‐Dose Extended‐Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery
Krieger, Carrie A., Cunningham, Julie L. , Langman, Loralie J., Grothe, Karen, Clark, Matthew M. , Dierkhising, Ross , Reid, Joel M. , Grothe, Karen B, Dierkhising, Ross A

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | August 28, 2017 | Volume: 37 | Issue: 11 | Pages: 1374-1382

10.1002/phar.2022 | PMID 28845898 Get It

Study Objective The extended‐release ( ER ) form of venlafaxine is preferred because of improved patient adherence, but the immediate‐release (IR) form is frequently used after Roux‐en‐Y gastric bypass ( RYGB ) surgery because of concerns for malabsorption. The objective of this study was to determine whether a statistically significant and predictable change in the bioavailability of venlafaxine ER capsules occurs after RYGB . Design Prospective nonblinded single‐dose pharmacokinetic study. Setting Clinical research unit at a large tertiary care medical practice. Patients Ten adult pre–bariatric surgery patients who met the criteria for noncomplicated RYGB were enrolled and served as their own controls. Interventions Patients were administered one venlafaxine ER 75‐mg capsule at two visits—the first visit at least 1 week before undergoing RYGB and the second visit 3–4 months after RYGB . Blood samples were collected at predetermined intervals over 48 hours after each dose, and the pharmacokinetics of venlafaxine were measured. Measurements and Main Results Plasma levels of venlafaxine and its primary metabolite, O ‐desmethylvenlafaxine ( ODV ), were compared at baseline and 3–4 months after RYGB . The areas under the serum concentration–time curves from 0–24 hours ( AUC 0–24 ) for venlafaxine (mean ± SD 734 ± 602 vs 630 ± 553 ng·hr/ml, p=0.22) and ODV (mean ± SD 894 ± 899 vs 1083 ± 972 ng·hr/ml, p=0.07) were similar before and after RYGB . Using a bioequivalence approach, differences in pre‐ RYGB and post‐ RYGB values of AUC 0–24 , peak serum concentration, and time to peak serum concentration were not statistically significant for either venlafaxine or ODV. Conclusion This study suggests that RYGB does not significantly alter the amount of venlafaxine or its active metabolite, ODV , absorbed from a venlafaxine ER capsule or the time over which it is absorbed.
Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Mangaonkar, Abhishek A. , Khateeb, Hassan Al, Duma, Narjust , Louis, Erik K. St. , Patnaik, Mrinal M. , Litzow, Mark R. , Kourelis, Taxiarchis , Mangaonkar, Abhishek A. , St Louis, Erik K, Hogan, William, St Louis, E K , McKeon, Andrew , Hogan, William J.

Case Reports in Hematology | August 27, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-4

10.1155/2017/6803804 | PMID 28928996 Get It

Background/Aims. Autonomic dysfunction (AD) after allogeneic stem cell transplant (SCT) is a rare occurrence and likely immune-mediated in etiology. There is limited literature on this topic and hence, we wish to briefly describe management of two cases at our institution and their outcomes. Methods. We retrospectively identified two patients with immune-mediated AD after SCT from our database. Immune-mediated AD was defined as AD secondary to an immune-mediated etiology without an alternative cause and responding to immunosuppression. Results. The first case is of a 32-year-old man with acute myeloid leukemia (AML) who underwent double umbilical cord allogeneic SCT. The second patient was a 51-year-old woman with secondary AML who underwent matched-related donor allogeneic SCT. Both underwent an extensive work-up for an underlying etiology prior to treatment with intravenous immunoglobulin (IVIG). Conclusions. AD after SCT is a rare yet significant clinical entity. A work-up of underlying etiology should be performed. IVIG is a treatment option for these patients.
Change in Anterior Cruciate Ligament Graft Choice and Outcomes Over Time
Kaeding, Christopher C. , Pedroza, Angela , Reinke, Emily K. , Huston, Laura J. , Hewett, Timothy E. , Flanigan, David C. , Group, MOON Knee, Brophy, Robert H. , Wolf, Brian R. , Jones, Morgan H. , McCarty, Eric C. , Brophy, Robert H. , Jones, Morgan H , Group, MOON knee, Spindler, Kurt P , McCarty, Eric C

Arthroscopy | August 26, 2017 | Volume: 33 | Issue: 11 | Pages: 2007-2014

10.1016/j.arthro.2017.06.019 | PMID 28847572 Get It

Purpose To analyze failure rate in 2‐year increments to determine if graft choice changed over time and graft failure rate. Methods A prospective 2002‐2008 database was used to identify risk factors for anterior cruciate ligament (ACL) retear. Subjects who had primary ACL retear with no history of contralateral surgery and 2‐year follow‐up were included. Subjects who underwent a multiligament reconstruction were excluded. Graft type, age, sex, smoking status, body mass index, Marx activity level at index surgery, medial and lateral meniscus status at time of ACL retear, sport played after ACL reconstruction, and clinical site were evaluated. Analysis was repeated using 2002‐2003 (early) and 2007‐2008 (late) 2‐year databases. Analysis of variance with post hoc analysis was performed to detect significant differences in age and Marx score by graft type over time. Results Two‐year follow‐up for graft failure was obtained on 2,497 of 2,692 (93%) subjects. There were 112 of 2,497 (4.5%) ACL retears identified at 2‐year follow‐up. The only predictor that changed between early/late periods was allograft use. Allograft odds ratio decreased from 13.1 to 9.5 ( P < .01). Allografts were used in older patients (31‐40 years) and with lower Marx scores (10‐8) from early to late periods. The mean age of subjects who received bone–patellar tendon–bone autografts did not significantly change over time (22.8‐23.5). The mean age of subjects who received hamstring autografts fell (27.9‐25.5). The mean age of subjects who received allografts rose significantly (31.3‐39.8, P < .01). The mean Marx score of subjects who received bone–patellar tendon–bone and hamstring autografts did not significantly change over time. The mean Marx score of subjects who received allografts decreased significantly ( P < .01). Conclusions After early recognition, allograft use in young active patients was a risk factor for retear; graft choice by surgeons changed in the late period to use of allografts in older and less‐active patients, which correlated with a significant decrease in retear risk. Level of Evidence Level III, case control study.